StockNews.com Initiates Coverage on Ampio Pharmaceuticals (NYSE:AMPE)

StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a report issued on Sunday morning. The brokerage issued a sell rating on the stock.

Ampio Pharmaceuticals Stock Performance

AMPE stock opened at $0.00 on Friday. The company has a market cap of $2,383.50, a price-to-earnings ratio of 0.00 and a beta of 3.78. Ampio Pharmaceuticals has a one year low of $0.00 and a one year high of $1.99.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.